InvestSMART

Dimerix Limited (ASX: DXB) - Announcements

- Current share price for DXB : $0.220

ASX company news and announcements for Dimerix Limited (DXB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Dimerix Limited (DXB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Dimerix Limited (DXB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Dimerix Limited (DXB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$132 Notification regarding unquoted securities - DXB 22 Oct 2024 1:27PM $0.448 $0.220 fallen by 50.84%
$132 Application for quotation of securities - DXB 15 Oct 2024 2:39PM $0.495 $0.220 fallen by 55.56%
$132 Results of Meeting 1 Oct 2024 3:45PM $0.365 $0.220 fallen by 39.73%
$132 Application for quotation of securities - DXB 1 Oct 2024 3:13PM $0.365 $0.220 fallen by 39.73%
$132 Chair Address and AGM Presentation 1 Oct 2024 12:40PM $0.380 $0.220 fallen by 42.11%
$132 Application for quotation of securities - DXB 17 Sep 2024 12:47PM $0.410 $0.220 fallen by 46.34%
$132 ACTION3 Trial Recruitment and Multiregion Trial Site Update 16 Sep 2024 8:28AM $0.415 $0.220 fallen by 46.99%
$132 Application for quotation of securities - DXB 13 Sep 2024 8:27AM $0.435 $0.220 fallen by 49.43%
$132 First Paediatric Site Activated and Trial Update 12 Sep 2024 8:45AM $0.390 $0.220 fallen by 43.59%
$132 Application for quotation of securities - DXB 11 Sep 2024 1:04PM $0.395 $0.220 fallen by 44.30%
$132 First patient enters into Open Label Extension study 10 Sep 2024 9:51AM $0.405 $0.220 fallen by 45.68%
$132 Letter to Shareholders, Notice of AGM & Proxy Form 2 Sep 2024 9:02AM $0.450 $0.220 fallen by 51.11%
$132 Appendix 4G and Corporate Governance Statement 29 Aug 2024 8:35AM $0.440 $0.220 fallen by 50%
$132 Annual Report 29 Aug 2024 8:34AM $0.440 $0.220 fallen by 50%
$132 Preliminary Final Report 29 Aug 2024 8:27AM $0.440 $0.220 fallen by 50%
$132 Application for quotation of securities - DXB 19 Aug 2024 9:41AM $0.455 $0.220 fallen by 51.65%
$132 Notification of Date of 2024 AGM 15 Aug 2024 8:36AM $0.440 $0.220 fallen by 50%
$132 Application for quotation of securities - DXB 7 Aug 2024 10:53AM $0.410 $0.220 fallen by 46.34%
$132 Change of Director's Interest Notice - HA & SP 31 Jul 2024 1:03PM $0.458 $0.220 fallen by 51.91%
$132 Notification of cessation of securities - DXB 31 Jul 2024 11:51AM $0.455 $0.220 fallen by 51.65%
$132 Dimerix presentation at Bio Connections Australia 29 Jul 2024 8:45AM $0.465 $0.220 fallen by 52.69%
$132 Application for quotation of securities - DXB 26 Jul 2024 1:59PM $0.470 $0.220 fallen by 53.19%
$132 Secondary Trading Notice Pursuant to Section 708A(5)(e) 26 Jul 2024 1:50PM $0.470 $0.220 fallen by 53.19%
$132 Application for quotation of securities - DXB 26 Jul 2024 1:43PM $0.470 $0.220 fallen by 53.19%
$132 Quarterly Appendix 4C and Activities Report 23 Jul 2024 2:45PM $0.575 $0.220 fallen by 61.74%

151 - 175 of 739 results

Page 7 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.